134 related articles for article (PubMed ID: 12901914)
21. Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma.
De Gasparo R; Brodbeck-Persch E; Bryson S; Hentzen NB; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
ChemMedChem; 2018 May; 13(9):957-967. PubMed ID: 29624890
[TBL] [Abstract][Full Text] [Related]
22. Coupling of a competitive and an irreversible ligand generates mixed type inhibitors of Trypanosoma cruzi trypanothione reductase.
Inhoff O; Richards JM; Brîet JW; Lowe G; Krauth-Siegel RL
J Med Chem; 2002 Sep; 45(20):4524-30. PubMed ID: 12238931
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase.
Duyzend MH; Clark CT; Simmons SL; Johnson WB; Larson AM; Leconte AM; Wills AW; Ginder-Vogel M; Wilhelm AK; Czechowicz JA; Alberg DG
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):784-94. PubMed ID: 22085139
[TBL] [Abstract][Full Text] [Related]
25. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
[TBL] [Abstract][Full Text] [Related]
26. Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds.
Jockers-Scherübl MC; Schirmer RH; Krauth-Siegel RL
Eur J Biochem; 1989 Mar; 180(2):267-72. PubMed ID: 2647489
[TBL] [Abstract][Full Text] [Related]
27. Betraying the parasite's redox system: diaryl sulfide-based inhibitors of trypanothione reductase: subversive substrates and antitrypanosomal properties.
Stump B; Kaiser M; Brun R; Krauth-Siegel RL; Diederich F
ChemMedChem; 2007 Dec; 2(12):1708-12. PubMed ID: 17918760
[No Abstract] [Full Text] [Related]
28. Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.
Vera B; Vázquez K; Mascayano C; Tapia RA; Espinosa V; Soto-Delgado J; Salas CO; Paulino M
J Biomol Struct Dyn; 2017 Jun; 35(8):1785-1803. PubMed ID: 27232454
[TBL] [Abstract][Full Text] [Related]
29. The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors.
Galarreta BC; Sifuentes R; Carrillo AK; Sanchez L; Amado Mdel R; Maruenda H
Bioorg Med Chem; 2008 Jul; 16(14):6689-95. PubMed ID: 18558492
[TBL] [Abstract][Full Text] [Related]
30. Molecular dynamics simulations of peptide inhibitors complexed with Trypanosoma cruzi trypanothione reductase.
Silva Da Rocha Pita S; Batista PR; Albuquerque MG; Pascutti PG
Chem Biol Drug Des; 2012 Oct; 80(4):561-71. PubMed ID: 22702225
[TBL] [Abstract][Full Text] [Related]
31. 2-Amino diphenylsulfides as inhibitors of trypanothione reductase: modification of the side chain.
Baillet S; Buisine E; Horvath D; Maes L; Bonnet B; Sergheraert C
Bioorg Med Chem; 1996 Jun; 4(6):891-9. PubMed ID: 8818240
[TBL] [Abstract][Full Text] [Related]
32. Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism.
Saccoliti F; Di Santo R; Costi R
ChemMedChem; 2020 Dec; 15(24):2420-2435. PubMed ID: 32805075
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of trypanothione reductase by substrate analogues.
Garrard EA; Borman EC; Cook BN; Pike EJ; Alberg DG
Org Lett; 2000 Nov; 2(23):3639-42. PubMed ID: 11073664
[TBL] [Abstract][Full Text] [Related]
34. Parasite-specific trypanothione reductase as a drug target molecule.
Krauth-Siegel RL; Inhoff O
Parasitol Res; 2003 Jun; 90 Suppl 2():S77-85. PubMed ID: 12709793
[TBL] [Abstract][Full Text] [Related]
35. Key proteins in the polyamine-trypanothione pathway as drug targets against Trypanosoma cruzi.
Maya JD; Salas CO; Aguilera-Venegas B; Diaz MV; López-Muñoz R
Curr Med Chem; 2014; 21(15):1757-71. PubMed ID: 24251576
[TBL] [Abstract][Full Text] [Related]
36. The synthesis and inhibitory activity of dethiotrypanothione and analogues against trypanothione reductase.
Czechowicz JA; Wilhelm AK; Spalding MD; Larson AM; Engel LK; Alberg DG
J Org Chem; 2007 May; 72(10):3689-93. PubMed ID: 17439174
[TBL] [Abstract][Full Text] [Related]
37. Trypanocidal bisbenzylisoquinoline alkaloids are inhibitors of trypanothione reductase.
Fournet A; Inchausti A; Yaluff G; Rojas De Arias A; Guinaudeau H; Bruneton J; Breidenbach MA; Karplus PA; Faerman CH
J Enzyme Inhib; 1998 Feb; 13(1):1-9. PubMed ID: 9879510
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of polyamine derivatives for the preparation of affinity chromatography columns for the search of new Trypanosoma cruzi targets.
Davioud-Charvet E; Berecibar A; Girault S; Landry V; Drobecq H; Sergheraert C
Bioorg Med Chem Lett; 1999 Jun; 9(11):1567-72. PubMed ID: 10386937
[TBL] [Abstract][Full Text] [Related]
39. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
Beltran-Hortelano I; Perez-Silanes S; Galiano S
Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
[TBL] [Abstract][Full Text] [Related]
40. Trypanothione reductase inhibition/trypanocidal activity relationships in a 1,4-bis(3-aminopropyl)piperazine series.
Bonnet B; Soullez D; Girault S; Maes L; Landry V; Davioud-Charvet E; Sergheraert C
Bioorg Med Chem; 2000 Jan; 8(1):95-103. PubMed ID: 10968268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
